Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a First National Institutes of Health/Office of Rare Diseases conference
Keywords: ACE; Angiotensin converting enzyme; ADPKD; Autosomal dominant polycystic kidney disease; ARB; Angiotensin II receptor blocker; ARPKD/CHF; Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis; cAMP; Cyclic adenosine monophosphate;